| Patent | Date |
|---|
Methods Of Treating Systemic Lupus Erythematosus Using A Domain Antibody Directed Against Cd28
App 20220144951 - Valencia; Xavier ; et al. | 2022-05-12 |
Antibody Polypeptides That Antagonize Cd40l
App 20220073636 - NADLER; Steven G. ; et al. | 2022-03-10 |
Methods of treating systemic lupus erythematosus using a domain antibody directed against CD28
Grant 11,267,888 - Valencia , et al. March 8, 2 | 2022-03-08 |
Antibody polypeptides that antagonize CD40L
Grant 11,180,567 - Nadler , et al. November 23, 2 | 2021-11-23 |
Cd71 Binding Fibronectin Type Iii Domains
App 20210145976 - Addis; Russell C. ; et al. | 2021-05-20 |
FN3 Domain-siRNA Conjugates and Uses Thereof
App 20210108201 - Addis; Russell C. ; et al. | 2021-04-15 |
Compositions Monovalent For Cd28 Binding And Methods Of Use
App 20210047414 - McKinnon; Murray ; et al. | 2021-02-18 |
Compositions monovalent for CD28 binding and methods of use
Grant 10,919,965 - McKinnon , et al. February 16, 2 | 2021-02-16 |
Methods Of Treating Systemic Lupus Erythematosus Using A Domain Antibody Directed Against Cd28
App 20200247890 - Kind Code | 2020-08-06 |
Methods Of Treating Transplant Rejection Using A Domain Antibody Directed Against Cd40l
App 20200231676 - SURI; Anish ; et al. | 2020-07-23 |
Antibody Polypeptides That Antagonize Cd40l
App 20190100595 - NADLER; Steven G. ; et al. | 2019-04-04 |
Methods Of Diagnosing And Treating Lupus
App 20190086405 - Menard; Laurence Celine ; et al. | 2019-03-21 |
Methods of treating immune diseases by administering antibody polypeptides that specifically bind CD40L
Grant 10,196,451 - Nadler , et al. Fe | 2019-02-05 |
Compositions Monovalent For Cd28 Binding And Methods Of Use
App 20180142023 - McKinnon; Murray ; et al. | 2018-05-24 |
Compositions monovalent for CD28 binding and methods of use
Grant 9,908,937 - McKinnon , et al. March 6, 2 | 2018-03-06 |
Antibody Polypeptides That Antagonize Cd40l
App 20180051091 - NADLER; Steven G. ; et al. | 2018-02-22 |
Antibody polypeptides that antagonize CD40L
Grant 9,765,150 - Nadler , et al. September 19, 2 | 2017-09-19 |
Methods Of Treating Systemic Lupus Erythematosus Using A Domain Antibody Directed Against Cd28
App 20170240636 - Valencia; Xavier ; et al. | 2017-08-24 |
Methods Of Treating Transplant Rejection Using A Domain Antibody Directed Against Cd40
App 20170051059 - SURI; Anish ; et al. | 2017-02-23 |
Antibody Polypeptides That Antagonize Cd40l
App 20160075790 - NADLER; Steven G. ; et al. | 2016-03-17 |
Antibody polypeptides that antagonize CD40L
Grant 9,228,018 - Nadler , et al. January 5, 2 | 2016-01-05 |
Compositions Monovalent For Cd28 Binding And Methods Of Use
App 20150299321 - McKinnon; Murray ; et al. | 2015-10-22 |
Compositions monovalent for CD28 binding and methods of use
Grant 9,085,629 - McKinnon , et al. July 21, 2 | 2015-07-21 |
Nucleic acids encoding antibody polypeptides that antagonize CD40L
Grant 8,981,072 - Nadler , et al. March 17, 2 | 2015-03-17 |
Antibody Polypeptides That Antagonize Cd40l
App 20150023976 - NADLER; Steven G. ; et al. | 2015-01-22 |
Antibody polypeptides that antagonize CD40L
Grant 8,895,010 - Nadler , et al. November 25, 2 | 2014-11-25 |
Antibody Polypeptides That Antagonize Cd40l
App 20140099707 - NADLER; Steven G. ; et al. | 2014-04-10 |
Compositions monovalent for CD28 binding and methods of use
Grant 8,454,959 - McKinnon , et al. June 4, 2 | 2013-06-04 |
Compositions Monovalent For Cd28 Binding And Methods Of Use
App 20130109846 - McKinnon; Murray ; et al. | 2013-05-02 |
Antibody Polypeptides That Antagonize Cd40l
App 20130095109 - NADLER; Steven G. ; et al. | 2013-04-18 |
Compositions Monovalent For Cd28 Binding And Methods Of Use
App 20120201814 - McKinnon; Murray ; et al. | 2012-08-09 |
Compositions monovalent for CD28 binding and methods of use
Grant 8,168,759 - McKinnon , et al. May 1, 2 | 2012-05-01 |
Polynucleotides And Polypeptides Associated With The Development Of Rheumatoid Arthritis
App 20100119509 - Carman; Julie ; et al. | 2010-05-13 |
Polynucleotides and polypeptides associated with the development of rheumatoid arthritis
Grant 7,670,785 - Carman , et al. March 2, 2 | 2010-03-02 |
Compositions Monovalent For Cd28 Binding And Methods Of Use
App 20100028354 - McKinnon; Murray ; et al. | 2010-02-04 |
Polynucleotides and polypeptides associated with the development of rheumatoid arthritis
App 20090004184 - Carman; Julie ; et al. | 2009-01-01 |
Compositions and methods involving glucocorticoid receptor site II
Grant 7,442,554 - Doweyko , et al. October 28, 2 | 2008-10-28 |
Polynucleotides and polypeptides associated with the development of rheumatoid arthritis
Grant 7,244,573 - Carman , et al. July 17, 2 | 2007-07-17 |
Compositions and methods involving nuclear hormone receptor site II
App 20060223110 - Doweyko; Arthur M.P. ; et al. | 2006-10-05 |
Methods of treating inflammatory and immune diseases using inhibitors of I.kappa.B kinase (IKK)
Grant 6,869,956 - Burke , et al. March 22, 2 | 2005-03-22 |
Polynucleotides and polypeptides associated with the NF-kappaB pathway
App 20040171823 - Nadler, Steven G. ; et al. | 2004-09-02 |
Polynucleotides and polypeptides associated with the NF-kB pathway
App 20040086896 - Carman, Julie ; et al. | 2004-05-06 |
Intracellular targeted delivery of compounds by 70 kD heat shock protein
Grant 6,730,302 - Fujihara , et al. May 4, 2 | 2004-05-04 |
Polynucleotides and polypeptides associated with the development of rheumatoid arthritis
App 20030170742 - Carman, Julie ; et al. | 2003-09-11 |
Polynucleotides and polypeptides associated with the development of osteoarthritis
App 20030170743 - Carman, Julie ; et al. | 2003-09-11 |
Methods of treating inflammatory and immune diseases using inhibitors of IkappaB kinase (IKK)
App 20030022898 - Burke, James R. ; et al. | 2003-01-30 |
Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof
Grant 5,877,282 - Nadler , et al. March 2, 1 | 1999-03-02 |
| 